KRISTYN-MAE ROSALES: Open Payments
NPI 1881160828 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 13 payments from 8 companies in 2025. Trend: 2023 $423 · 2024 $184 · 2025 $441
Food & beverage: $346Education: $95
| Company | Payments | Amount |
|---|---|---|
| Verastem, Inc. | 1 | $124 |
| SEAGEN INC. | 1 | $95 |
| Merck Sharp & Dohme LLC | 4 | $73 |
| Syndax Pharmaceuticals, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $36 |
| Deciphera Pharmaceuticals Inc. | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: AVMAPKI FAKZYNJA CO-PACK, KEYTRUDA, PADCEV, QINLOCK, ZYNYZ, LYNOZYFIC, LYNPARZA.
Industry payments across TX — which companies pay providers there.
